What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Buy
62
CTAS Quote, Financials, Valuation and Earnings
Last price:
$214.18
Seasonality move
:
4.99%
Day range:
$215.22 - $218.26
52-week range:
$164.93 - $228.12
Dividend yield:
0.7%
P/E ratio:
49.87x
P/S ratio:
8.73x
P/B ratio:
18.93x
Volume:
1.4M
Avg. volume:
2M
1-year change:
24.81%
Market cap:
$86.9B
Revenue:
$9.6B
EPS (TTM):
$4.32
CTAS Analysts' Consensus Rating
The 16 analysts providing 12-month price projections for Cintas shares anticipate an average target of $209.54, ranging from a low estimate of $163.00 to a high estimate of $250.00. This average target implies a growth of -2.69% compared to the current stock price of $215.33.
Consensus Price Target
$209.54
Highest Price Target
$250.00
Lowest Price Target
$163.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 5 | 5 |
| Hold | 9 | 9 | 8 |
| Sell | 3 | 2 | 3 |
| Consensus | Hold | Hold | Hold |
CTAS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 4.72% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 2.36% over the past day.
